WO2023021433 - IMPROVED MANUFACTURING PROCESS
National phase entry:
Publication Number
WO/2023/021433
Publication Date
23.02.2023
International Application No.
PCT/IB2022/057697
International Filing Date
17.08.2022
Title **
[English]
IMPROVED MANUFACTURING PROCESS
[French]
PROCÉDÉ DE FABRICATION AMÉLIORÉ
Applicants **
HALEON (SUZHOU) PHARMACEUTICAL CO., LTD.
4 Baodai West Road
Suzhou, Jiangsu 215128, CN
Inventors
JIANG, Shaobo
,
KHAN, Mohammed Majed
,
Priority Data
PCT/CN2021/113487
19.08.2021
CN
21201234.8
06.10.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1257 | |
| EPO | Filing, Examination | 5661 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 2710 |
Total: 10826 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to improved methods and processes for producing ibuprofen arginine salt and particles or granules thereof. The invention further relates to soluble solid free-flowing compositions comprising Ibuprofen-arginine salt and sucrose, particularly pharmaceutical compositions comprising same, in the form of water-soluble powders and granules.[French]
La présente invention concerne des procédés et des processus améliorés de production de sel d'ibuprofène-arginine et de particules ou de granulés de celui-ci. L'invention concerne en outre des compositions solides à écoulement libre comprenant un sel d'ibuprofène-arginine et du saccharose, en particulier des compositions pharmaceutiques les comprenant, sous la forme de poudres et de granulés solubles dans l'eau.